MedPath

PF MONENSIN PREMIX 20% W/W GRANULE

Registration Number: MAL22036023HA

Approved
Approval ID

7fcbcd6cf73d9acc

Registration Number

MAL22036023HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25 kgAvailable
Package Size: 25 kg
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

MONENSIN SODIUMActive
Monograph: monensin sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PF MONENSIN PREMIX 20% W/W GRANULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform